Tata Chemicals International Pte. Limited (TCIPL), a wholly owned subsidiary of Tata Chemicals Limited, has executed a Share Purchase Agreement (SPA) to acquire 100% equity share capital of Novabay Pte. Limited (Novabay). The acquisition is contingent upon the fulfillment of various conditions precedent as specified in the SPA and is expected to be completed by March 2026. Novabay is a Singapore-based company engaged in the manufacture and sale of premium grade sodium bicarbonate, serving Pharma, Food, Personal Care in Europe, Americas, Oceania, ASIA, Middle East, and ASEAN markets. Its issued and paid-up share capital is US$ 35,532,140. For Calendar Year 2024, Novabay's turnover was SGD 29.49 Million (approximately ₹182 crore). The company was incorporated in November 2015 and is a wholly owned subsidiary of Novacarb, based in France. Novabay's turnover for CY2023 was SGD 25.93 Million and for CY2022 was SGD 27.68 Million. The acquisition is in line with Tata Chemicals' strategic intent to strengthen its capabilities in premium-grade products. Novabay is among the largest premium sodium bicarbonate producers in the Asia-Pacific region (excluding China), holding key cGMP, API, and related certifications, supported by a fully automated facility. With a current capacity of approximately 60,000 tons and potential to expand to 100,000 tons, Novabay is well-positioned for growth. The cash consideration for the acquisition is at an enterprise value of EUR 25 Million (equivalent to approximately SGD 37.8 Million), subject to net debt, net working capital, and other customary adjustments. The proposed acquisition does not fall within related party transactions, and the promoter/promoter group/group companies of Tata Chemicals have no interest in Novabay. No governmental or regulatory approvals are required for the proposed acquisition.